Cargando…
13. ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
Overall Abstract: There are converging lines of evidence that the endocannabinoid system is involved in the pathophysiology of schizophrenia and that understanding these mechanisms may lead to novel treatment targets. In this symposium, we will present a series of experiments that link cannabinoid p...
Autor principal: | Bloomfield, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887729/ http://dx.doi.org/10.1093/schbul/sby014.048 |
Ejemplares similares
-
13.1 ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
por: Moreira, Fabricio
Publicado: (2018) -
Sex differences in endocannabinoid modulation of rat CA1 dendritic neurotransmission
por: Ferraro, Angelica, et al.
Publicado: (2020) -
Inhibitory neurotransmission drives endocannabinoid degradation to promote memory consolidation
por: Dubois, Christophe J., et al.
Publicado: (2020) -
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
por: Sambo, Danielle O., et al.
Publicado: (2017) -
Detection of dopamine neurotransmission in “real time”
por: Badgaiyan, Rajendra D.
Publicado: (2013)